Resonance Health Ltd
ASX:RHT

Watchlist Manager
Resonance Health Ltd Logo
Resonance Health Ltd
ASX:RHT
Watchlist
Price: 0.048 AUD Market Closed
Market Cap: AU$22.8m

Relative Value

RHT doesn't have a meaningful market cap.

The Relative Value of one RHT stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.048 AUD, Resonance Health Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RHT Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

RHT Competitors Multiples
Resonance Health Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Resonance Health Ltd
ASX:RHT
22.1m AUD 2 -12.7 -12.2 -12.2
US
Abbott Laboratories
NYSE:ABT
196.7B USD 4.4 30.1 17.1 23.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
178.1B USD 17.7 62.4 47.5 58.4
US
Stryker Corp
NYSE:SYK
143.8B USD 5.7 44.3 22.4 27.1
IE
Medtronic PLC
NYSE:MDT
125.6B USD 3.5 27.2 14.7 21.4
US
Boston Scientific Corp
NYSE:BSX
112.8B USD 5.6 38.9 23.1 31
DE
Siemens Healthineers AG
XETRA:SHL
46.8B EUR 2 22 12.2 17.1
US
Becton Dickinson and Co
NYSE:BDX
52B USD 2.4 29.6 11.3 19
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.9B USD 11.8 48 34.3 37.9
US
Edwards Lifesciences Corp
NYSE:EW
45.8B USD 7.5 42.6 23.6 25.8
US
Resmed Inc
NYSE:RMD
37.5B USD 7 25.3 17.9 19.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Resonance Health Ltd
ASX:RHT
Average EV/EBITDA: 22.4
Negative Multiple: -12.2
N/A N/A
US
Abbott Laboratories
NYSE:ABT
17.1
9%
1.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
47.5
23%
2.1
US
Stryker Corp
NYSE:SYK
22.4
12%
1.9
IE
Medtronic PLC
NYSE:MDT
14.7
8%
1.8
US
Boston Scientific Corp
NYSE:BSX
23.1
18%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
12.2
11%
1.1
US
Becton Dickinson and Co
NYSE:BDX
11.3
8%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.3
11%
3.1
US
Edwards Lifesciences Corp
NYSE:EW
23.6
13%
1.8
US
Resmed Inc
NYSE:RMD
17.9
11%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Resonance Health Ltd
ASX:RHT
Average EV/EBIT: 28.1
Negative Multiple: -12.2
N/A N/A
US
Abbott Laboratories
NYSE:ABT
23.3
17%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.4
25%
2.3
US
Stryker Corp
NYSE:SYK
27.1
16%
1.7
IE
Medtronic PLC
NYSE:MDT
21.4
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
31
27%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
17.1
15%
1.1
US
Becton Dickinson and Co
NYSE:BDX
19
21%
0.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.9
11%
3.4
US
Edwards Lifesciences Corp
NYSE:EW
25.8
14%
1.8
US
Resmed Inc
NYSE:RMD
19.9
12%
1.7